Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: AORT

Artivion, Inc.

Healthcare | Medical - Devices

No licensed closing price on file for AORT. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$-0.06

Artivion, Inc. (NYSE: AORT) is a medical device company. Figures from SEC EDGAR; updated 2026-10-20 14:21 UTC.

What Artivion, Inc. does

Artivion manufactures and distributes medical devices and implantable human tissues for cardiac and vascular surgical procedures, particularly for patients with aortic disease. The company operates through two segments: Medical Devices, which sells aortic stent grafts, surgical sealants, and mechanical heart valves; and Preservation Services, which provides preservation of cardiac and vascular implantable human tissues.

Summarized from Artivion, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS (TTM)$-0.06
Debt/equity0.82

Revenue, margins & earnings

FY2021: net loss $15M on revenue $299M$299MFY2021FY2022: net loss $19M on revenue $314M$314MFY2022FY2023: net loss $31M on revenue $354M$354MFY2023FY2024: net loss $13M on revenue $389M$389MFY2024FY2025 Net income: $10MFY2025 Taxes & interest: $24MFY2025 Operating expenses: $250MFY2025 Cost of revenue: $157M$441MFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-11
  • 2026-09-11SVP, Regulatory and QualitySale-11,480$286.7K
  • 2026-09-04SVP, Regulatory and QualitySale-1,493$38.8K
  • 2026-09-04SVP, Regulatory and QualitySale-6,510$177.5K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Artivion, Inc. do?

Artivion manufactures and distributes medical devices and implantable human tissues for cardiac and vascular surgical procedures, particularly for patients with aortic disease.

When did AORT last file with the SEC?

Artivion, Inc.'s most recent SEC filing on record is a 8-K filed 2026-05-18. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 14:21 UTC. This page is also available as JSON at /api/data?ticker=AORT and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for AORT and 5,000+ tickers.

Create a free account — keep AORT
For your agent
GET /api/data?ticker=AORT

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt